CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 450 enrolled
Drug / intervention
Cigarettes +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03863509
NCT03863509N/ACompleted
CompareCT.gov

E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease Risk (Aka CLUES - Cardiac and Lung E-cig Smoking Study)

University of Wisconsin, Madison·observational·Posted Mar 5, 2019·Updated Aug 21, 2023

In Brief

An observational study evaluating Cigarettes and E-Cigarettes for Tobacco Use and 3 related conditions. Completed, enrolled 450 participants across 1 site.

Detailed Summary

This study is designed to enhance the understanding of the possible health effects of e-cigarette use by relating the acute and long-term use of e-cigarettes and conventional cigarettes ("products") to well-validated cardiovascular and pulmonary disease biomarkers. Participants will be enrolled in 3 groups: exclusive e-cigarette users, exclusive cigarette smokers, and a control group of never-users. Participants can expect up to 4 weeks of study participation.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Use, E-Cigarette Use, Cardiovascular Diseases, Pulmonary Disease
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 5, 2019
Enrollment StartMar 5, 2019
Primary CompletionMar 9, 2022
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 7.3 years ago

Interventions

Cigarettesbehavioral

smokes daily

E-Cigarettesbehavioral

E-cigarette usage \>/= 5 days/week